CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,960,447 | -21.3% | 668,038 | -42.2% | 0.03% | -18.8% |
| Q2 2023 | $12,662,996 | +2.6% | 1,156,438 | -18.3% | 0.03% | 0.0% |
| Q1 2023 | $12,337,387 | +387.6% | 1,414,838 | +250.6% | 0.03% | +357.1% |
| Q4 2022 | $2,530,183 | +90.4% | 403,538 | +6.2% | 0.01% | +75.0% |
| Q3 2022 | $1,329,000 | +205.5% | 379,838 | +157.5% | 0.00% | +300.0% |
| Q2 2022 | $435,000 | +10.1% | 147,538 | +16.1% | 0.00% | 0.0% |
| Q1 2022 | $395,000 | -37.6% | 127,038 | -32.1% | 0.00% | -50.0% |
| Q4 2021 | $633,000 | -54.8% | 187,138 | -51.2% | 0.00% | -50.0% |
| Q3 2021 | $1,401,000 | -62.1% | 383,738 | -54.8% | 0.00% | -60.0% |
| Q2 2021 | $3,699,000 | -38.2% | 848,338 | -35.6% | 0.01% | -37.5% |
| Q1 2021 | $5,983,000 | -14.2% | 1,317,938 | +8.4% | 0.02% | -15.8% |
| Q4 2020 | $6,977,000 | +136.1% | 1,215,438 | +197.8% | 0.02% | +137.5% |
| Q3 2020 | $2,955,000 | +127.1% | 408,138 | +9.5% | 0.01% | +100.0% |
| Q2 2020 | $1,301,000 | +149.7% | 372,638 | +5.8% | 0.00% | +100.0% |
| Q1 2020 | $521,000 | +118.9% | 352,238 | +190.5% | 0.00% | +100.0% |
| Q4 2019 | $238,000 | -16.8% | 121,238 | +463.9% | 0.00% | 0.0% |
| Q1 2019 | $286,000 | +50.5% | 21,500 | -11.2% | 0.00% | 0.0% |
| Q4 2018 | $190,000 | -55.1% | 24,200 | -36.6% | 0.00% | 0.0% |
| Q3 2018 | $423,000 | -51.2% | 38,200 | -40.9% | 0.00% | -50.0% |
| Q2 2018 | $867,000 | -10.0% | 64,600 | -12.8% | 0.00% | -33.3% |
| Q1 2018 | $963,000 | +618.7% | 74,100 | +407.5% | 0.00% | – |
| Q4 2017 | $134,000 | +20.7% | 14,600 | +5.8% | 0.00% | – |
| Q3 2017 | $111,000 | – | 13,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |